Direct medical costs of adverse events in Dutch hospitals
L H F Hoonhout(EMGO Institute for Health and Care Research), Maurits W. van Tulder(Vrije Universiteit Amsterdam), Peter Spreeuwenberg(Netherlands Institute for Health Services Research), Marieke Zegers(Radboud University Medical Center), Martine C. de Bruijne(EMGO Institute for Health and Care Research), Cordula Wagner(Netherlands Institute for Health Services Research), Roelof Waaijman(EMGO Institute for Health and Care Research), Gerrit van der Wal(Amsterdam Public Health), Henk Asscheman
Cited by 136
Related Papers
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.4k
Adverse events and potentially preventable deaths in Dutch hospitals: results of a retrospective patient record review study
|BMJ Quality & Safety|2009|473
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19
|JAMA|2022|282
New Physical, Mental, and Cognitive Problems 1 Year after ICU Admission: A Prospective Multicenter Study
|American Journal of Respiratory and Critical Care Medicine|2021|260
The incidence, root-causes, and outcomes of adverse events in surgical units: implication for potential prevention strategies
|Patient Safety in Surgery|2011|207